Eunice Kagucia/Vaccine

Lessons learnt during establishment of COVID-19 active vaccine safety surveillance in nine African countries.Cutland CL, Gutu K, Yun JA, Izu A, Mahtab S, Peter J, Ansah NA, Obaro S, Tilahun B, Jambo K, Sow S, Kagucia EW, Chicumbe S, Dlamini T, Browne M, Clothier H, Griffin J, Jiang Y, Lee A, Ghebreab L, Madhi SA, Black SB
Vaccine, (2025). 62:127441

Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009-2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016.Mburu CN, Ojal J, Selim R, Ombati R, Akech D, Karia B, Tuju J, Sigilai A, Smits G, van Gageldonk PGM, van der Klis FRM, Flasche S, Kagucia EW, Scott JAG, Adetifa IMO
Vaccine, (2025). 61:127425

The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort study.Lucinde RK, Karia B, Ouma N, Amadi D, Nyundo C, Mataza C, Nyaguara A, Scott JAG, Gallagher KE, Kagucia E
Vaccine, (2023). 41:666-675